Plasma levels and vascular effects of vasopressin in patients undergoing coronary artery bypass grafting☆
Author(s) -
Susaovella,
Ana Cristina Martı́nez,
Rosa María Pagán,
Medardo Hernández,
Albino Garcı́a-Sacristán,
Ángel GonzálezPinto,
José María GonzálezSantos,
Sara Benedito
Publication year - 2007
Publication title -
european journal of cardio-thoracic surgery
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.303
H-Index - 133
eISSN - 1873-734X
pISSN - 1010-7940
DOI - 10.1016/j.ejcts.2007.03.047
Subject(s) - vasopressin , medicine , endocrinology , artery , superoxide dismutase , nitric oxide , endothelin receptor , chemistry , oxidative stress , receptor
Recent studies have suggested that endogenous vasopressin (AVP) acts as a spasmogen during coronary artery bypass grafting (CABG). Given that AVP could induce vasospasm in the grafted vessel, we assessed the release of this peptide during and after CABG, and explored ways of counteracting its contractile effect on the internal mammary artery (IMA).
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom